Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 | Rezvan MitraChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $74K 3,782 sh | Jan 8, 2026 |
| 19 | Gnanasambandam ChandrasekarEVP Product & CTO | Open-market sale · 10b5-1 plan | SELL | $83K 4,245 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Gnanasambandam ChandrasekarEVP Product & CTO | Open-market sale · 10b5-1 plan | SELL | $87K 4,360 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 19 | Payne AbbyChief People Officer | Open-market sale · 10b5-1 plan | SELL | $186K 9,329 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 19 | Blue David LawrenceSee Remarks | Grant or award | A | $13K 1,041 sh | Jan 8, 2026 traded Dec 31, 2025 |
| 19 | Schmitt ChristopherGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $88K 4,507 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 19 | Ahearn Matthew FraserDirector, Chief Operating Officer | Grant or award | A | $5,800 477 sh | Jan 8, 2026 traded Dec 31, 2025 |
| 19 | Points Jeffrey S.Chief Financial Officer | Grant or award | A | $13K 1,076 sh | Jan 8, 2026 traded Dec 31, 2025 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $919K 4,610 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $512K 2,543 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $814K 4,099 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $841K 4,447 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 18 | Shipchandler KhozemaDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $1.50M 11.1K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 18 | Gravier PierreCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $165K 2,139 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 18 | Issa Mohamed KhairieEVP, Head of US Oncology | Open-market sale · 10b5-1 plan | SELL | $1.18M 10.9K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 18 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $712K 3,815 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $33K 9,722 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 17 | Frew JamesSEE REMARKS | Option exercise | M | — 55.8K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Boone KarenDirector | Option exercise | M | — 1,460 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 7,500 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 17 | Henderson Tracey KExecutive VP Exploration | Grant or award | A | — 18.3K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Giles Bryan ECHIEF FINANCIAL OFFICER | Grant or award | A | — 34.2K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Willis Eric M.See Remarks | Option exercise | M | — 29.5K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $35K 9,722 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 17 | Lopez Anthony WilliamSEE REMARKS | Option exercise | M | — 17.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Hamilton James CChief Medical Officer | Grant or award | A | — 75.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Borgeson BlakeDirector | Open-market sale · 10b5-1 plan | SELL | $959K 220.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $396K 5,149 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Edwards Carladenise ArmbristerDirector | Grant or award | A | — 79.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Wu Joanne CGeneral Counsel and Secretary | Grant or award | A | — 25.2K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 17 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $36K 9,730 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 16 | Wu Joanne CGeneral Counsel and Secretary | Tax withholding | F | $149K 12.7K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 16 | Giles Bryan ECHIEF FINANCIAL OFFICER | Tax withholding | F | $208K 17.6K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 16 | Frew JamesSEE REMARKS | Tax withholding | F | $109K 23.9K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 16 | Lakkundi Veena MPres, Performance Surfaces | Grant or award | A | $50K 1,341 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 16 | Ajami DariushChief Innovation Officer | Tax withholding | F | $194K 207.3K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 16 | Willis Eric M.See Remarks | Tax withholding | F | $60K 13.2K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 15 | Peterson Neil W.CHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $450K 5,000 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 15 | Marathe AjayChief Operating Officer | Tax withholding | F | $369K 42.6K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 15 | Wall Cecil CDirector | Grant or award | A | $18K 23.1K sh | Jan 8, 2026 traded Jan 5, 2026 |